Traditional toxicity testing methods may not be adequate for nanomaterials. Therefore, new approaches are needed for risk assessment. This includes understanding the biopersistence of nanomaterials, their potential to cause inflammation, and their ability to cross biological barriers like the blood-brain barrier.
